Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anika Therapeutics Inc (NASDAQ:ANIK)

49.09
Delayed Data
As of Feb 22
 -0.11 / -0.22%
Today’s Change
38.34
Today|||52-Week Range
54.96
+0.27%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues75.1M105.6M93.0M103.4M
 
 
 
 
 
Cost of Goods Sold18.0M16.2M17.3M24.0M
 
 
 
 
 
Depreciation And Amortization4.8M4.7M3.8M--
 
 
 
 
 
Operating ExpensesGross Income52.3M84.7M71.9M79.4M
 
 
 
 
 
General Expenses20.0M23.2M23.8M28.7M
 
 
 
 
 
Research And Development7.1M8.1M9.0M10.7M
 
 
 
 
 
Total Operating Expenses42.8M44.1M44.9M52.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income32.3M61.4M48.1M50.6M
 
 
 
 
 
Extraordinary Credit286.8K0.000.00--
 
 
Interest Expense On Debt127.2K0.00----
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income32.5M61.5M48.3M50.9M
 
 
 
 
 
Income Taxes-11.9M-23.2M-17.5M-18.3M
 
 
 
 
 
Net Income20.6M38.3M30.8M32.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.1M14.7M14.9M14.7M
 
 
 
 
 
Shares To Calculate EPS Diluted14.8M15.3M15.3M15.1M
 
 
 
 
 
 
Earnings Per ShareEPS$1.39$2.51$2.01$2.15
 
 
 
 
 
EPS Diluted$1.39$2.51$2.01$2.15